Cross-national comparative study of orphan drug policies in Saudi Arabia, the United States, and the European Union

Background: Rare diseases are chronic, serious, and life-threatening conditions that have not received sufficient attention from drug developers due to their rarity. Policies have been implemented to encourage research and incentivize the development of orphan drugs. However, the implementation of t...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Saudi Pharmaceutical Journal
المؤلفون الرئيسيون: Bander Balkhi, Asma Almuaither, Saeed Alqahtani
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Springer 2023-09-01
الموضوعات:
الوصول للمادة أونلاين:http://www.sciencedirect.com/science/article/pii/S1319016423002335